1Cutolo M,Capellino S, Montagna P, et al. Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of Tlym- phocytes and synovial macrophages fromrheumatoid arthritis patients[ J]. Ann Rheum Dis,2006,65(6) :728-735.
2Antony T,Jose VM, Paul BJ, et al. Efficacy and safety of leflunomide alone and in combination with methotrexate in the treatment of re- fractory rheumatoid arthritis [ J ]. Indian J Med Sei, 2006,60 ( 8 ) : 318-326.
3Pan F, Ebbs A, Wynn C, et al. FK778, a powerful new immunosup- pressant, effectively reduces functional and histologic changes ofchronic rejection in rat renal allografts [J]. Transplantation,2003,75 ( 8 ) : 1110- 1114.
4van Woerkom JM, Kruize AA, Geenen R, et al. Safety and efficacy of leflunomide in primary Sjogrens syndrome: a phase pilot study[ J]. Ann Rheum Dis ,200766 (8) : 1026-1032.
7Reich K, Hummel KM, Beckmann I, et al. Treatment of severe psoriasis and psoriatic arthritis with leflunomide [ J ]. Br J Dermatol, 2002,146 (2)335-336.
8Nash P, Thaci D, Behrens F, et al. Leflunomide improves psoriasis in patients with psoriatic arthritis: allin-depth analysis of data from the TOPAS study [ J ]. Dermatology,2006,12 ( 3 ) : 238 -249.
